A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers.
Malek OkourGeo DerimanovRodger BarnettEsther FernandezSantiago FerrerStephanie GreshamMohammad HossainFrancisco-Javier GamoGavin KohAdrian PereiraKatie RolfeDeborah WongGraeme YoungHarshad RamiJohn HaseldenPublished in: British journal of clinical pharmacology (2017)
The information generated by this study provides a basis for predicting the expected oral PK profiles of GSK3191607 in man and supports decisions on the future clinical development of the compound.